Clinical Trials Directory

Trials / Sponsors / Verona Pharma plc

Verona Pharma plc

Industry · 18 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
CompletedA Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensif
Chronic Obstructive Pulmonary Disease
Phase 22025-10-06
RecruitingA Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Chronic Obstructive Pulmonary Disease
Phase 22025-07-31
RecruitingA Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Phase 22024-09-11
CompletedA Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD
Chronic Obstructive Pulmonary Disease
Phase 22024-08-16
CompletedEffect of Ensifentrine Treatment on CAT Score
COPD
Phase 32024-06-11
RecruitingEffect of Ensifentrine on Sputum Markers of Inflammation in COPD
COPD
Phase 22022-05-27
CompletedA Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Chronic Obstructive Pulmonary Disease
Phase 32020-09-29
CompletedA Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Chronic Obstructive Pulmonary Disease
Phase 32020-09-22
CompletedStudy Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
COPD
Phase 22019-05-01
CompletedA Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease
COPD
Phase 22019-04-29
CompletedStudy Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler
Pulmonary Disease, Chronic Obstructive
Phase 22018-12-10
CompletedBronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD
COPD
Phase 22018-07-16
CompletedDose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients
COPD
Phase 22017-06-01
CompletedA Study of RPL554 in Patients With Cystic Fibrosis
Cystic Fibrosis
Phase 22017-02-08
CompletedThe Effects of RPL554 in Addition to Tiotropium in COPD Patients
Chronic Obstructive Pulmonary Disease Moderate
Phase 22017-01-01
CompletedThe Effects of RPL554 on Top of Standard COPD Reliever Medications
Chronic Obstructive Pulmonary Disease
Phase 22015-10-01
CompletedComparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients
Asthma
Phase 22015-04-01
CompletedSAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects
Inflammatory Disorder of the Respiratory Tract, Chronic Obstructive Pulmonary Disorder
Phase 12014-12-01